HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Fadlo R Khuri Selected Research
Fadlo R Khuri Research Topics
Disease
189
Neoplasms (Cancer)
01/2022 - 01/2002
69
Lung Neoplasms (Lung Cancer)
04/2021 - 01/2002
56
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2021 - 05/2002
39
Squamous Cell Carcinoma of Head and Neck
01/2019 - 03/2002
24
Head and Neck Neoplasms (Head and Neck Cancer)
11/2020 - 01/2004
13
Carcinogenesis
11/2015 - 07/2002
11
Neoplasm Metastasis (Metastasis)
01/2017 - 05/2003
6
Small Cell Lung Carcinoma (Small Cell Lung Cancer)
12/2020 - 05/2012
6
Neutropenia
08/2017 - 03/2002
5
Multiple Myeloma
07/2015 - 12/2005
5
Carcinoma (Carcinomatosis)
09/2009 - 07/2002
4
Thyroid Neoplasms (Thyroid Cancer)
05/2022 - 01/2013
4
Adenocarcinoma of Lung
11/2017 - 01/2008
4
Colonic Neoplasms (Colon Cancer)
01/2017 - 12/2006
4
Squamous Cell Carcinoma (Epidermoid Carcinoma)
09/2014 - 01/2002
4
Neurodegenerative Diseases (Neurodegenerative Disease)
10/2011 - 04/2006
4
Fever (Fevers)
04/2010 - 03/2002
3
Fatigue
12/2020 - 03/2004
3
Pain (Aches)
12/2020 - 12/2004
3
Melanoma (Melanoma, Malignant)
01/2018 - 01/2017
3
Leukemia
09/2014 - 08/2014
3
Hypoxia (Hypoxemia)
12/2011 - 04/2010
3
Diarrhea
09/2011 - 05/2004
Drug/Important Bio-Agent (IBA)
32
Proteins (Proteins, Gene)
FDA Link
01/2022 - 08/2004
19
ErbB Receptors (EGF Receptor)
IBA
03/2016 - 05/2004
15
Biomarkers (Surrogate Marker)
IBA
11/2020 - 07/2003
14
TNF-Related Apoptosis-Inducing Ligand Receptors
IBA
12/2015 - 10/2004
13
Erlotinib Hydrochloride (CP 358,774)
FDA Link
07/2015 - 06/2004
13
Ligands
IBA
04/2013 - 01/2006
12
Everolimus
FDA Link
05/2022 - 08/2010
12
Paclitaxel (Taxol)
FDA Link
Generic
04/2021 - 07/2002
12
TOR Serine-Threonine Kinases
IBA
12/2014 - 08/2005
12
Retinoids
IBA
07/2012 - 02/2003
11
Phosphotransferases (Kinase)
IBA
07/2015 - 10/2004
11
Cyclooxygenase 2 (Cyclooxygenase-2)
IBA
08/2014 - 05/2004
11
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
01/2012 - 01/2006
10
Cisplatin (Platino)
FDA Link
Generic
01/2019 - 01/2002
9
Death Domain Receptors
IBA
02/2021 - 12/2004
9
Celecoxib (Celebrex)
FDA Link
03/2014 - 12/2004
9
Docetaxel (Taxotere)
FDA Link
03/2013 - 03/2002
9
lonafarnib (SCH 66336)
IBA
09/2011 - 05/2004
9
Isotretinoin (Accutane)
FDA Link
Generic
04/2007 - 01/2002
8
Enzymes
IBA
01/2018 - 10/2011
8
Epidermal Growth Factor (EGF)
IBA
12/2016 - 01/2009
7
Curcumin
IBA
01/2016 - 01/2007
7
taxane
IBA
10/2015 - 05/2004
7
Farnesyltranstransferase (Farnesyltransferase)
IBA
06/2007 - 07/2002
6
Mitogen-Activated Protein Kinase Kinases (MEKs)
IBA
01/2018 - 12/2008
6
Carboplatin (JM8)
FDA Link
Generic
08/2017 - 07/2002
6
Small Interfering RNA (siRNA)
IBA
05/2015 - 10/2007
6
Sirolimus (Rapamycin)
FDA Link
04/2015 - 08/2005
6
Tyrosine Kinase Inhibitors
IBA
04/2015 - 09/2008
6
DNA (Deoxyribonucleic Acid)
IBA
04/2015 - 10/2011
6
Eukaryotic Initiation Factor-4E
IBA
03/2013 - 11/2007
5
MTOR Inhibitors
IBA
02/2021 - 11/2007
5
Platinum
IBA
01/2018 - 04/2009
5
Caspase 8 (Caspase-8)
IBA
12/2015 - 10/2007
5
Proteasome Inhibitors
IBA
07/2015 - 01/2006
5
Tyrosine (L-Tyrosine)
FDA Link
09/2014 - 11/2009
5
Protein-Tyrosine Kinases (Tyrosine Kinase)
IBA
03/2011 - 06/2004
5
Taxoids (Taxanes)
IBA
04/2010 - 06/2002
5
beta Carotene (Betacarotene)
FDA Link
02/2009 - 01/2002
5
retinol palmitate (retinyl palmitate)
FDA Link
02/2009 - 01/2002
4
Deoxyglucose (2 Deoxy D glucose)
IBA
04/2021 - 04/2008
4
RNA (Ribonucleic Acid)
IBA
01/2021 - 04/2015
4
Anaplastic Lymphoma Kinase
IBA
03/2016 - 09/2012
4
Messenger RNA (mRNA)
IBA
10/2015 - 09/2002
4
Smoke
IBA
03/2014 - 12/2004
4
Tubulin
IBA
03/2014 - 01/2006
4
Transferases
IBA
09/2011 - 06/2004
4
Tea
IBA
06/2010 - 01/2007
4
Bortezomib (Velcade)
FDA Link
05/2010 - 01/2006
4
Triterpenes
IBA
09/2008 - 10/2004
4
bardoxolone methyl
IBA
09/2008 - 10/2004
4
alpha-Tocopherol
FDA Link
04/2007 - 07/2003
4
Insulin-Like Peptides
IBA
10/2004 - 12/2002
4
Insulin-Like Growth Factor Binding Protein 3
IBA
10/2004 - 12/2002
3
Monoclonal Antibodies
IBA
01/2018 - 04/2004
3
human ERBB2 protein
IBA
11/2017 - 10/2015
3
Selenium
IBA
11/2017 - 01/2005
3
Cetuximab (Erbitux)
FDA Link
02/2017 - 07/2014
3
acetoacetic acid (acetoacetate)
IBA
01/2017 - 08/2015
3
Protein Isoforms (Isoforms)
IBA
01/2017 - 01/2008
3
Cytokines
IBA
10/2015 - 05/2007
3
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
08/2014 - 05/2004
3
Glucose (Dextrose)
FDA Link
Generic
08/2014 - 11/2009
3
14-3-3 Proteins (14-3-3 Protein)
IBA
05/2014 - 11/2008
3
Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)
IBA
03/2014 - 12/2004
3
Carrier Proteins (Binding Protein)
IBA
11/2013 - 04/2010
3
Peptide Initiation Factors (Initiation Factor)
IBA
03/2012 - 08/2009
3
Tretinoin (Retinoic Acid)
FDA Link
Generic
08/2011 - 01/2002
3
perifosine
IBA
12/2010 - 07/2007
3
Ubiquitin
IBA
05/2010 - 12/2006
3
Proteasome Endopeptidase Complex (Proteasome)
IBA
05/2010 - 12/2006
Therapy/Procedure
67
Therapeutics
12/2020 - 01/2002
27
Drug Therapy (Chemotherapy)
08/2017 - 01/2002
25
Chemoprevention
11/2020 - 01/2002
15
Radiotherapy
12/2020 - 05/2002
5
Induction Chemotherapy
09/2009 - 07/2002
3
Salvage Therapy
12/2020 - 04/2010